FDA Approved: MARGENZA — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for Margenza (margetuximab-cmkb) submitted by TerSera Therapeutics LLC, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MARGENZA (MARGETUXIMAB-CMKB)

Snippet

SUPPL AP for MARGENZA (MARGETUXIMAB-CMKB)